BioCentury
ARTICLE | Company News

GeoVax, Georgia State deal

January 27, 2017 9:08 PM UTC

GeoVax and the university partnered to develop GeoVax's vaccine candidates to treat chronic HBV infections. The partners will use GeoVax's Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) vaccin...